Yes, all Rare Cannabinoid Company products are produced in a cGMP facility. cGMP refers to the current Good Manufacturing Practice regulations enforced by the U.S. Food and Drug Administration (FDA).
cGMP is the main regulatory standard for ensuring the quality of pharmaceutical medicines. Although our products are not pharmaceutical drugs, this regulation ensures that each batch of every product meets the highest quality standards and consumers can be assured that they are safe. cGMPs provide systems that assure proper design, monitoring and control of manufacturing processes and facilities. Adherence to the cGMP regulations assures customers of the identity, strength, quality and purity of products.
cGMPs are important because a consumer cannot usually detect (through smell, touch, sight or taste) if a CBD or rare cannabinoid product is safe. It is therefore important that, in addition to independent lab testing, that they are manufactured in facilities that are in good condition, equipment that is properly maintained and calibrated, employees who are qualified and fully trained, and processes that are reliable and reproducible. This certification ensures all of those quality controls.